Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine versus hydroxyzine for uremic pruritus in hemodialysis patients
IRCT20120314009297N9Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in chronic kidney disease-associated pruritus (CKD-aP) comparing Mirtazapine arm with Hydroxyzine arm (2 arms). Primary endpoint: Change in itch intensity. Started Oct 2023; status: completed.
02
Drugs
mirtazapinehydroxyzine
03
Conditions
chronic kidney disease-associated pruritus (CKD-aP)
Beyond the preview
Go deeper on IRCT20120314009297N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120314009297N9.